: Identified as having a 57.8% upside potential relative to its current low trading price.

: A leader in the electric vertical takeoff and landing (eVTOL) space. While currently pre-revenue, analysts project revenue will scale from approximately $32 million in 2026 to over $1.7 billion by 2029.

: A biotech play trading near $4.03 with a massive projected sales growth of 103.99% for the next year.